ConductScience.org, home

Paper · 5477666

Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.

Breslow A. Ann Surg, 1970. Cited by 1,989 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Papers, record 5477666. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5477666

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.
PubMed
Journal
Ann Surg
PubMed
Year
1970
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1,989
iCite
Relative citation ratio, by iCite
51.2
iCite
Revised in PubMed
2024-01-03
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Breslow AA

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MelanomaMajor topic
Skin NeoplasmsMajor topic
Adolescent
Adult
Aged
Female
Humans
Male
Melanins
Melanocytes
Middle Aged
Neoplasm Metastasis
Prognosis

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References3

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15,930,185Clinical study of forty-nine patients with malignant melanoma.Cancer1966https://conductscience.org/library/papers/5930185PubMed
26,074,148The surgical management of patients with melanoma.Plast Reconstr Surg1967https://conductscience.org/library/papers/6074148PubMed
35,773,814The histogenesis and biologic behavior of primary human malignant melanomas of the skin.Cancer Res1969https://conductscience.org/library/papers/5773814PubMed

Cited by384

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,989 citations.

PMIDTitleJournalYearIn PapersSource
42,684,448[TNM classification of melanoma : Evolution and limitations].Pathologie (Heidelb)2026https://conductscience.org/library/papers/42684448PubMed
42,540,073Utilizing relative survival to investigate melanoma subtypes across intersectional demographics: a Surveillance, Epidemiology, and End Results (SEER) cohort study.Skin Health Dis2026https://conductscience.org/library/papers/42540073PubMed
42,356,028Assessment of Risk Factors Correlated with Satellites and In-Transit Metastases in Primary Cutaneous Melanomas.Medicina (Kaunas)2026https://conductscience.org/library/papers/42356028PubMed
42,352,153Towards Accurate Breslow Measurements: Mitigating Issues in Histopathological Imaging.Entropy (Basel)2026https://conductscience.org/library/papers/42352153PubMed
42,216,301Time to Stop Clerking Clark?Australas J Dermatol2026https://conductscience.org/library/papers/42216301PubMed
42,165,691Malignant Melanoma Misdiagnosis in the Diabetic Foot. What Can We Learn From the Published Literature?J Foot Ankle Res2026https://conductscience.org/library/papers/42165691PubMed
41,987,696Demographics of malignant melanoma in Trinidad and Tobago.Ann R Coll Surg Engl2026https://conductscience.org/library/papers/41987696PubMed
41,961,742Evaluation of the Contribution of Repeat Total Body Photography for the Early Diagnosis of Melanoma.Dermatology2026https://conductscience.org/library/papers/41961742PubMed
41,869,222Polypoid Melanoma: A Rare and Aggressive Variant.Cureus2026https://conductscience.org/library/papers/41869222PubMed
41,778,962AI-derived prognostic biomarkers from melanoma whole slide image segmentation: an initial discovery and assessment.J Pathol Clin Res2026https://conductscience.org/library/papers/41778962PubMed

1 to 10 of 384

See all 384 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/5477666

GET https://conductscience.org/api/papers/v1/5477666/cited_by?page=2